Literature DB >> 1799276

Antisense oligodeoxynucleotides as antiviral agents.

J S Cohen1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1799276     DOI： 10.1016/0166-3542(91)90019-n

Source DB:  PubMed          Journal:  Antiviral Res        ISSN： 0166-3542            Impact factor:   5.970


× No keyword cloud information.
  10 in total

1.  In vitro inhibition of hepatitis C virus gene expression by chemically modified antisense oligodeoxynucleotides.

Authors:  O Vidalin; M E Major; B Rayner; J L Imbach; C Trépo; G Inchauspé
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

Review 2.  Translation-targeted therapeutics for viral diseases.

Authors:  J B Harford
Journal:  Gene Expr       Date:  1995

3.  Folate-mediated targeting of antisense oligodeoxynucleotides to ovarian cancer cells.

Authors:  S Li; H M Deshmukh; L Huang
Journal:  Pharm Res       Date:  1998-10       Impact factor: 4.200

Review 4.  Anti-AIDS drug development: challenges and strategies.

Authors:  P Mohan
Journal:  Pharm Res       Date:  1992-06       Impact factor: 4.200

5.  In vivo generation of highly abundant sequence-specific oligonucleotides for antisense and triplex gene regulation.

Authors:  S B Noonberg; G K Scott; M R Garovoy; C C Benz; C A Hunt
Journal:  Nucleic Acids Res       Date:  1994-07-25       Impact factor: 16.971

6.  Specific inhibition of aphthovirus infection by RNAs transcribed from both the 5' and the 3' noncoding regions.

Authors:  A Gutiérrez; E Martínez-Salas; B Pintado; F Sobrino
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

7.  Synthesis of oligodeoxynucleoside methylphosphonates utilizing the tert-butylphenoxyacetyl group for exocyclic amine protection.

Authors:  N D Sinha; D P Michaud; S K Roy; R A Casale
Journal:  Nucleic Acids Res       Date:  1994-08-11       Impact factor: 16.971

8.  Deprotection of methylphosphonate oligonucleotides using a novel one-pot procedure.

Authors:  R I Hogrefe; M M Vaghefi; M A Reynolds; K M Young; L J Arnold
Journal:  Nucleic Acids Res       Date:  1993-05-11       Impact factor: 16.971

9.  Anti-human immunodeficiency virus type 1 activity of phosphorothioate analogs of oligodeoxynucleotides: penetration and localization of oligodeoxynucleotides in HIV-1-infected MOLT-4 cells.

Authors:  H Nakashima; Y Shoji; S G Kim; J Shimada; Y Mizushima; M Ito; N Yamamoto; H Takaku
Journal:  Nucleic Acids Res       Date:  1994-11-25       Impact factor: 16.971

Review 10.  Antisense technology for cancer therapy: does it make sense?

Authors:  G Carter; N R Lemoine
Journal:  Br J Cancer       Date:  1993-05       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.